Biovie Inc
(BIVI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46 | N/A | 2 | N/A | 5 |
| TOTAL | $46 | $N/A | $2 | $N/A | $5 |
| Non-Current Assets | |||||
| Intangibles | 2,130 | 0 | 2,244 | 0 | 2,359 |
| TOTAL | $2,130 | $N/A | $2,244 | $N/A | $2,359 |
| Total Assets | $2,176 | $N/A | $2,246 | $N/A | $2,364 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 354 | N/A | N/A | N/A | 35 |
| Accounts payable and accrued liabilities | 884 | 0 | 629 | 0 | 471 |
| Accrued Expenses | 354 | N/A | 250 | N/A | 125 |
| TOTAL | $1,238 | $N/A | $879 | $N/A | $631 |
| Non-Current Liabilities | |||||
| Long Term Debt | 576 | N/A | 576 | N/A | 576 |
| TOTAL | $576 | $N/A | $576 | $N/A | $576 |
| Total Liabilities | $2,064 | $N/A | $1,455 | $N/A | $1,207 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 973 | 950 | 946 | N/A |
| Common Shares | 10 | N/A | 10 | N/A | 9 |
| Retained earnings | -4,769 | N/A | -3,501 | N/A | -2,335 |
| TOTAL | $111 | $N/A | $791 | $N/A | $1,157 |
| Total Liabilities And Equity | $2,176 | $0 | $2,246 | $0 | $2,364 |